Similar articles

Abstract: epigallocatechin-3-gallate (EGCG), a bioactive polyphenol abundant in green tea, has garnered significant attention for its diverse therapeutic applications, ranging from antioxidant and anti-inflammatory effects to potential anticancer properties. Despite its immense promise, the practical utilization of EGCG in therapeutic settings as a medication has been hampered by inherent limitations of this drug, including poor bioavailability, instability, and rapid degradation. This review comprehensively explores the current challenges associated with the application of EGCG and evaluates the potential of nanoparticle-based formulations in addressing these limitations. nanoparticles, with their unique physicochemical properties, offer a platform for the enhanced stability, bioavailability, and targeted delivery of EGCG. Various nanoparticle strategies, including polymeric nanoparticle, micelle, lipid-based nanocarrier, metal nanoparticle, and silica nanoparticle, are currently employed to enhance EGCG stability and pharmacological activity. This review concludes that the particle sizes of most of these formulated nanocarriers fall within 300 nm and their encapsulation efficiency ranges from 51% to 97%. Notably, the pharmacological activities of EGCG-loaded nanoparticles, such as antioxidative, anti-inflammatory, anticancer, and antimicrobial effects, are significantly enhanced compared to those of free EGCG. By critically analyzing the existing literature and highlighting recent advancements, this article provides valuable insights into the promising prospects of nanoparticle-mediated EGCG formulations, paving the way for the development of more effective and clinically viable therapeutic strategies.

EGCG作为治疗剂：纳米载体策略最新进展与挑战的系统综述

[1]AlamM, AliS, AshrafGM, et al., 2022. Epigallocatechin 3-gallate: from green tea to cancer therapeutics. Food Chem, 379:132135.

[2]AlizadehL, AlizadehE, ZarebkohanA, et al., 2020. AS1411 aptamer-functionalized chitosan-silica nanoparticles for targeted delivery of epigallocatechin gallate to the SKOV-3 ovarian cancer cell lines. J Nanopart Res, 22:5.

[3]AlrashdiBM, FehaidA, KassabRB, et al., 2023. Biosynthesized selenium nanoparticles using epigallocatechin gallate protect against pentylenetetrazole-induced acute epileptic seizures in mice via antioxidative, anti-inflammatory, and anti-apoptotic activities. Biomedicines, 11(7):1955.

[4]AlserihiRF, MohammedMRS, KaleemM, et al., 2021. Development of (‍-)‍-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment. Nanotechnol Rev, 11(1):298-311.

[5]BottenD, FugalloG, FraternaliF, et al., 2015. Structural properties of green tea catechins. J Phys Chem B, 119(40):12860-12867.

[6]CaiZY, LiXM, LiangJP, et al., 2018. Bioavailability of tea catechins and its improvement. Molecules, 23(9):2346.

[7]CanoA, EttchetoM, EspinaM, et al., 2018. Epigallocatechin-3-gallate loaded PEGYlated-PLGA nanoparticles: a new anti-seizure strategy for temporal lobe epilepsy. Nanomed Nanotechnol Biol Med, 14(4):1073-1085.

[8]CanoA, EttchetoM, ChangJH, et al., 2019. Dual-drug loaded nanoparticles of epigallocatechin-3-gallate (EGCG)/ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer’s disease mice model. J Control Release, 301:62-75.

[9]ChandraP, AroraDS, 2018. Antioxidant compounds derived from plants, description and mechanism of phytochemicals. J Agroecol Natural Resour Manag, 4(1):55-59.

[10]ChavvaSR, DeshmukhSK, KanchanapallyR, et al., 2019. Epigallocatechin gallate-gold nanoparticles exhibit super

[11]ior antitumor activity compared to conventional gold nanoparticles: potential synergistic interactions. Nanomaterials, 9(3):396.

[12]ChengCY, BarroL, TsaiST, et al., 2021. Epigallocatechin-3-gallate-loaded liposomes favor anti-inflammation of microglia cells and promote neuroprotection. Int J Mol Sci, 22(6):3037.

[13]CunhaL, CoelhoSC, Do Carmo PereiraM, et al., 2022. Nanocarriers based on gold nanoparticles for epigallocatechin gallate delivery in cancer cells. Pharmaceutics, 14(3):491.

[14]DahanA, MillerJM, 2012. The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs. AAPS J, 14(2):‍244-251.

[15]DaiWZ, RuanCC, ZhangYM, et al., 2020a. Bioavailability enhancement of EGCG by structural modification and nano-delivery: a review. J Funct Foods, 65:103732.

[16]DaiWZ, RuanCC, SunY, et al., 2020b. Controlled release and antioxidant activity of chitosan and β‍-lactoglobulin complex nanoparticles loaded with epigallocatechin gallate. Colloids Surf B Biointerfaces, 188:110802.

[17]DongJQ, CarpinonePL, PyrgiotakisG, et al., 2020. Synthesis of precision gold nanoparticles using Turkevich method. KONA Powder Part J, 37:224-232.

[18]DymekM, SikoraE, 2022. Liposomes as biocompatible and smart delivery systems – the current state. Adv Colloid Interface Sci, 309:102757.

[19]FarabegoliF, GranjaA, MagalhãesJ, et al., 2022. Epigallocatechin-3-gallate delivered in nanoparticles increases cytotoxicity in three breast carcinoma cell lines. ACS Omega, 7(46):41872-41881.

[20]FurniturewallaA, BarveK, 2022. Approaches to overcome bioavailability inconsistencies of epigallocatechin gallate, a powerful anti-oxidant in green tea. Food Chem Adv, 1:100037.

[21]GanN, WakayamaC, InubushiS, et al., 2022. Size dependency of selective cellular uptake of epigallocatechin gallate-modified gold nanoparticles for effective radiosensitization. ACS Appl Bio Mater, 5(1):355-365.

[22]HaddadF, MohammedN, GopalanRC, et al., 2023. Development and optimisation of inhalable EGCG nano-liposomes as a potential treatment for pulmonary arterial hypertension by implementation of the design of experiments approach. Pharmaceutics, 15(2):539.

[23]HammamiI, AlabdallahNM, JomaaAA, et al., 2021. Gold nanoparticles: synthesis properties and applications. J King Saud Univ Sci, 33(7):101560.

[24]HeAJ, GuanX, SongHD, et al., 2020. Encapsulation of (-)-epigallocatechin-gallate (EGCG) in hordein nanoparticles. Food Biosci, 37:100727.

[25]HeJT, XuL, YangL, et al., 2018. Epigallocatechin gallate is the most effective catechin against antioxidant stress via hydrogen peroxide and radical scavenging activity. Med Sci Monit, 24:8198-8206.

[26]HigdonJV, FreiB, 2003. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr, 43(1):89-143.

[27]HoCH, ChuPY, PengSL, et al., 2020. The development of hyaluronan/fucoidan-based nanoparticles as macrophages targeting an epigallocatechin-3-gallate delivery system. Int J Mol Sci, 21(17):6327.

[28]Hoyos-CeballosGP, Sánchez-GiraldoV, Mendivil-PerezM, et al., 2018. Design of epigallocatechin gallate loaded PLGA/PF127 nanoparticles and their effect upon an oxidative stress model. J Drug Deliv Sci Technol, 48:152-160.

[29]HuQM, YangZ, ZhangYY, et al., 2021. Efficient development of antibacterial (‍-)‍-epigallocatechin gallate-PBCA nanoparticles using ethyl acetate as oil phase through interfacial polymerization. Food Biosci, 44:101432.

[30]HuXP, ZhangYT, DingTT, et al., 2020. Multifunctional gold nanoparticles: a novel nanomaterial for various medical applications and biological activities. Front Bioeng Biotechnol, 8:556510.

[31]HuangHY, WangMC, ChenZY, et al., 2018. Gelatin‍–epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief. Int J Nanomed, 13:7251-7273.

[32]HuangTW, HoYC, TsaiTN, et al., 2020. Enhancement of the permeability and activities of epigallocatechin gallate by quaternary ammonium chitosan/fucoidan nanoparticles. Carbohydr Polym, 242:116312.

[33]HuangYM, LiP, ZhaoRK, et al., 2022. Silica nanoparticles: biomedical applications and toxicity. Biomed Pharmacother, 151:113053.

[34]JiangC, ChenY, YeX, et al., 2021. Three flavanols delay starch digestion by inhibiting α‍-amylase and binding with starch. Int J Biol Macromol, 172:503-514.

[35]KahramanE, GüngörS, ÖzsoyY, 2017. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Ther Deliv, 8:‍967-985.

[36]KarAK, SinghA, DhimanN, et al., 2019. Polymer-assisted in situ synthesis of silver nanoparticles with epigallocatechin gallate (EGCG) impregnated wound patch potentiate controlled inflammatory responses for brisk wound healing. Int J Nanomed, 14:9837-9854.

[37]KaziJ, SenR, GangulyS, et al., 2020. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft. Int J Pharm, 585:119449.

[38]KhanMY, RoyM, 2019. Synthesis, limitation and application of gold nanoparticles in treatment of cancerous cell. Int J Sci Res Multidiscip Stud, 5(9):8-14.

[39]KhorYY, LeeSK, Dharmani DeviM, et al., 2023. Epigallocatechin-3-gallate exerts antihypertensive effects and improves endothelial function in spontaneously hypertensive rats. Asian Pac J Trop Biomed, 13(7):‍287-295.

[40]KlębowskiB, DepciuchJ, Parlińska-WojtanM, et al., 2018. Applications of noble metal-based nanoparticles in medicine. Int J Mol Sci, 19(12):4031.

[41]KoopaieM, 2020. 22-Nanoparticulate systems for dental drug delivery. In: Mozafari M (Ed.), Nanoengineered Biomaterials for Advanced Drug Delivery. Elsevier, Amsterdam, p.525-559.

[42]KrzyzowskaM, JanickaM, ChodkowskiM, et al., 2023. Epigallocatechin gallate-modified silver nanoparticles show antiviral activity against herpes simplex type 1 and 2. Viruses, 15(10):2024.

[43]KühneBA, PuigT, Ruiz-MartínezS, et al., 2019. Comparison of migration disturbance potency of epigallocatechin gallate (EGCG) synthetic analogs and EGCG pegylated PLGA nanoparticles in rat neurospheres. Food Chem Toxicol, 123:195-204.

[44]LadduD, MaJ, KaarJ, et al., 2021. Health behavior change programs in primary care and community practices for cardiovascular disease prevention and risk factor management among midlife and older adults: a scientific statement from the American Heart Association. Circulation, 144(24):e533-e549.

[45]LiZY, MuYW, PengC, et al., 2021. Understanding the mechanisms of silica nanoparticles for nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 13(1):e1658.

[46]LiuC, WuH, DuanHX, et al., 2023. An EGCG-mediated self-assembled micellar complex acts as a bioactive drug carrier. Food Chem, 418:135939.

[47]LiuZX, LiXL, WuXP, et al., 2019. A dual-inhibitor system for the effective antifibrillation of Aβ40 peptides by biodegradable EGCG-Fe(III)/PVP nanoparticles. J Mater Chem B, 7(8):1292-1299.

[48]LuHY, ZhangSL, WangJL, et al., 2021. A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr, 8:783831.

[49]MaCY, ZhouXC, YuHR, et al., 2024. Virtual screening and multi-synergism of inhibitory compounds against pancreatic lipase. Food Biosci, 57:103601.

[50]MilliganJJ, SahaS, 2022. A nanoparticle’s journey to the tumor: strategies to overcome first-pass metabolism and their limitations. Cancers, 14(7):1741.

[51]MinnelliC, MorettiP, FulgenziG, et al., 2018. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: characterization and protective effect against oxidative damage. Int J Pharm, 552(1-2):225-234.

[52]MinnelliC, StipaP, SabbatiniS, et al., 2023. Insights into PLGA-encapsulated epigallocatechin 3-gallate nanoparticles as a new potential biomedical system: a computational and experimental approach. Eur Polym J, 182:111723.

[53]MohdSabri NA, LeeSK, MuruganDD, et al., 2022. Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS. Sci Rep, 12:17633.

[54]MokraD, AdamcakovaJ, MokryJ, 2022. Green tea polyphenol (‍-)‍-epigallocatechin-3-gallate (EGCG): a time for a new player in the treatment of respiratory diseases? Antioxidants, 11(8):1566.

[55]Moreno-VásquezMJ, Plascencia-JatomeaM, Sánchez-ValdesS, et al., 2021. Characterization of epigallocatechin-gallate-grafted chitosan nanoparticles and evaluation of their antibacterial and antioxidant potential. Polymers, 13(9):1375.

[56]MostafaSM, Gamal-EldeenAM, MaksoudNAE, et al., 2020. Epigallocatechin gallate-capped gold nanoparticles enhanced the tumor suppressors let-7a and miR-34a in hepatocellular carcinoma cells. An Acad Bras Cienc, 92(4):1-13.

[57]MüllerRH, RadtkeM, WissingSA, 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 54:S131-S155.

[58]NagarV, SinghT, TiwariY, et al., 2022. ZnO nanoparticles: exposure, toxicity mechanism and assessment. Mater Today Proc, 69:56-63.

[59]National Center for Biotechnology Information, 2024. PubChem compound summary for CID 65064, epigallocatechin gallate. https://pubchem.‍ncbi.‍nlm.‍nih.‍gov/compound/Epigallocatechin-Gallate [Accessed on Jan. 2, 2024].

[60]NsairatH, KhaterD, SayedU, et al., 2022. Liposomes: structure, composition, types, and clinical applications. Heliyon, 8(5):e09394.

[61]OmoruyiF, SparksJ, StennettD, et al., 2020. Superoxide dismutase as a measure of antioxidant status and its application to diabetes. In: Preedy VR (Ed.), Diabetes: Oxidative Stress and Dietary Antioxidants, 2nd Ed. Elsevier, Amsterdam, p.409-417.

[62]ParnKW, LingWC, ChinJH, et al., 2022. Safety and efficacy of dietary epigallocatechin gallate supplementation in attenuating hypertension via its modulatory activities on the intrarenal renin-angiotensin system in spontaneously hypertensive rats. Nutrients, 14(21):4605.

[63]PerumalS, AtchudanR, LeeW, 2022. A review of polymeric micelles and their applications. Polymers, 14(12):2510.

[64]PissuwanD, GazzanaC, MongkolsukS, et al., 2020. Single and multiple detections of foodborne pathogens by gold nanoparticle assays. WIREs Nanomed Nanobiotechnol, 12(1):e1584.

[65]PushpalathaC, SureshJ, GayathriV, et al., 2022. Zinc oxide nanoparticles: a review on its applications in dentistry. Front Bioeng Biotechnol, 10:917990.

[66]RadhakrishnanR, KulhariH, PoojaD, et al., 2016. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem Phys Lipids, 198:51-60.

[67]RadhakrishnanR, PoojaD, KulhariH, et al., 2019. Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment. Chem Phys Lipids, 224:104770.

[68]RietveldA, WisemanS, 2003. Antioxidant effects of tea: evidence from human clinical trials. J Nutr, 133(10):‍3285S-3292S.

[69]RositaN, MeitasariVA, RiantiMC, et al., 2019. Enhancing skin penetration of epigallocatechin gallate by modifying partition coefficient using reverse micelle method. Ther Deliv, 10(7):409-417.

[70]RyabovaYV, SutunkovaMP, MinigalievaIA, et al., 2024. Toxicological effects of selenium nanoparticles in laboratory animals: a review. J Appl Toxicol, 44(1):4-16.

[71]SafwatMA, KandilBA, ElblbesyMA, et al., 2020. Epigallocatechin-3-gallate-loaded gold nanoparticles: preparation and evaluation of anticancer efficacy in Ehrlich tumor-bearing mice. Pharmaceuticals, 13(9):254.

[72]SampathS, SunderamV, ManjushaM, et al., 2024. Selenium nanoparticles: a comprehensive examination of synthesis techniques and their diverse applications in medical research and toxicology studies. Molecules, 29(4):801.

[73]SamutprasertP, ChiablaemK, TeeraseraneeC, et al., 2018. Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. RSC Adv, 8(14):7369-7376.

[74]SelvarajanV, ObuobiS, EePLR, 2020. Silica nanoparticles—a versatile tool for the treatment of bacterial infections. Front Chem, 8:526915.

[75]SeverinoJF, GoodmanBA, KayCWM, et al., 2009. Free radicals generated during oxidation of green tea polyphenols: electron paramagnetic resonance spectroscopy combined with density functional theory calculations. Free Radical Biol Med, 46(8):1076-1088.

[76]SharmaS, VijayP, PathakPK, et al., 2019. Role of nanotechnology in oral cancer diagnosis and therapeutics. Med Res Chronicles, 6(4):192-199.

[77]SibliniH, Al-HendyA, SegarsJ, et al., 2023. Assessing the hepatic safety of epigallocatechin gallate (EGCG) in reproductive-aged women. Nutrients, 15(2):320.

[78]Siew-KeahL, JieTH, Ang-LimC, et al., 2023. An update on impacts of epigallocatechin gallate co-administration in modulating pharmacokinetics of statins, calcium channel blockers, and beta-blockers. Planta Med, 89(13):‍1229-1235.

[79]SilvaAM, Martins-GomesC, FangueiroJF, et al., 2019. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines. Pharm Dev Technol, 24(10):1243-1249.

[80]SinghNA, BhardwajV, RaviC, et al., 2018a. EGCG nanoparticles attenuate aluminum chloride induced neurobehavioral deficits, beta amyloid and tau pathology in a rat model of Alzheimer’s disease. Front Aging Neurosci, 10:374009.

[81]SinghNA, MandalAKA, KhanZA, 2018b. Inhibition of Al(III)‍-induced Aβ₄₂ fibrillation and reduction of neurotoxicity by epigallocatechin-3-gallate nanoparticles. J Biomed Nanotechnol, 14(6):1147-1158.

[82]SongHD, WangQY, HeAJ, et al., 2022. Antioxidant activity, storage stability and in vitro release of epigallocatechin-3-gallate (EGCG) encapsulated in hordein nanoparticles. Food Chem, 388:132903.

[83]TalluriSV, KuppusamyG, KarriVVSR, et al., 2015. Lipid-based nanocarriers for breast cancer treatment-comprehensive review. Drug Del, 23(4):1291-1305.

[84]TanHJ, LingWC, ChuaAL, et al., 2021. Oral epigallocatechin gallate reduces intestinal nadolol absorption via modulation of Oatp1a5 and Oct1 transcriptional levels in spontaneously hypertensive rats. Phytomedicine, 90:153623.

[85]TianM, ChenGC, XuJC, et al., 2022. Epigallocatechin gallate-based nanoparticles with reactive oxygen species scavenging property for effective chronic periodontitis treatment. Chem Eng J, 433:132197.

[86]WadaY, TakataA, IkemotoT, et al., 2019. The protective effect of epigallocatechin 3-gallate on mouse pancreatic islets via the Nrf2 pathway. Surg Today, 49(6):536-545.

[87]WangYM, LuoWQ, LinF, et al., 2022. Epigallocatechin-3-gallate selenium nanoparticles for neuroprotection by scavenging reactive oxygen species and reducing inflammation. Front Bioeng Biotechnol, 10:989602.

[88]WenLH, WuD, TanXD, et al., 2022. The role of catechins in regulating diabetes: an update review. Nutrients, 14(21):4681.

[89]XiaC, GuCM, LiuG, et al., 2023. Preparation of a novel brain-targeted EGCG liposome and its antioxidative neuroprotection. J Funct Foods, 111:105911.

[90]XuJZ, YeungSYV, ChangQ, et al., 2004. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br J Nutr, 91(6):873-881.

[91]YaoJJ, MaQQ, ShenWW, et al., 2022. Nano-enabled delivery of EGCG ameliorates silica-induced pulmonary fibrosis in rats. Toxicology, 469:153114.

[92]YaqoobAA, AhmadH, ParveenT, et al., 2020. Recent advances in metal decorated nanomaterials and their various biological applications: a review. Front Chem, 8:528583.

[93]YounK, HoCT, JunM, 2022. Multifaceted neuroprotective effects of (‍-)‍-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β‍-amyloid peptide. Food Sci Hum Wellness, 11(3):483-493.

[94]ZhangGJ, ZhangJF, 2018. Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats. Drug Des Dev Ther, 12:2509-2518.

[95]ZhangMY, GaoXJ, SuYJ, et al., 2023. Fabrication of egg white protein/phosphatidylcholine-EGCG co-assembled nanoparticles with sustained release in simulated gastrointestinal digestion and their transcellular permeability in Caco-2 cultures. Food Hydrocoll, 143:108906.

[96]ZhangWJ, ShenHC, LiY, et al., 2023. Preparation of type-A gelatin/poly-‍γ‍-glutamic acid nanoparticles for enhancing the stability and bioavailability of (‍-)‍-epigallocatechin gallate. Foods, 12(9):1748.

[97]ZhangY, LinLF, CuiH, et al., 2021. Construction and application of EGCG-loaded lysozyme/pectin nanoparticles for enhancing the resistance of nematodes to heat and oxidation stresses. Foods, 10(5):1127.

[98]ZhouXH, WuY, ZhouXJ, et al., 2022. Elaboration of cationic soluble soybean polysaccharides-epigallocatechin gallate nanoparticles with sustained antioxidant and antimicrobial activities. J Agric Food Chem, 70(36):11353-11366.

[99]ZhouXQ, HayatZ, ZhangDD, et al., 2023. Zinc oxide nanoparticles: synthesis, characterization, modification, and applications in food and agriculture. Processes, 11(4):1193.

[100]ZhuQY, ZhangAQ, TsangD, et al., 1997. Stability of green tea catechins. J Agric Food Chem, 45(12):4624-4628.

[101]ZhuST, ZhuLX, YuJJ, et al., 2019. Anti-osteoclastogenic effect of epigallocatechin gallate-functionalized gold nanoparticles in vitro and in vivo. Int J Nanomed, 14:5017-5032.

[102]ZwolakI, 2021. Epigallocatechin gallate for management of heavy metal-induced oxidative stress: mechanisms of action, efficacy, and concerns. Int J Mol Sci, 22(8):4027.